Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 87441-013

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 87441-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

87441-013-01 Label (8744101301)

This is a description of medication Atorvastatin Calcium Tablets, USP 40 mg. Each film-coated tablet contains Atorvastatin equivalent to 44 mg of atorvastatin calcium. It is recommended to see the package insert for usual dosage information. Pharmacists should dispense the medication guide to each patient separately and store the tablets in a tight container at controlled room temperature. The tablets have been repackaged by Unit Dose Solutions, INC. and distributed by Tuckahoe Enterprises, LLC.*

FDA Label Image

Figure-01 (Figure 01)

FDA Label Image

Figure-02 (Figure 02)

This text provides data on cumulative hazard percentage and a comparison related to Atorvastatin with a Hazard Ratio of 0.53 (95% CI: 0.45-0.83). It seems to be related to a study or research analysis involving a time-to-event endpoint through a four-year follow-up period.*

FDA Label Image

Figure-03 (Figure 03)

This text provides information about the percentage of subjects experiencing E vert after taking two different medications - Horvastatin 10 mg and Sorvastatin 80 mg. It also includes the hazard ratio (HR) and P-value related to the cardiovascular endpoints over time.*

FDA Label Image

Chemical-structure (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.